AFRM Stock Recent News
AFRM LATEST HEADLINES
In the latest trading session, Affirm Holdings (AFRM) closed at $47.38, marking a -1.95% move from the previous day.
The final trades of the day with the Fast Money traders.
NEW YORK, NY / ACCESS Newswire / March 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. ("Affirm" or the "Company") (NASDAQ:AFRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
Fintech giant Affirm Holdings Inc (NASDAQ:AFRM) is 3% lower to trade at $46.87 this afternoon, heading for a third consecutive loss and adding more weight to its already steep 28.3% year-to-date deficit.
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
NEW YORK CITY, NY / ACCESS Newswire / March 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. ("Affirm" or the "Company") (NASDAQ:AFRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.
AFRM expands its reach with J.P. Morgan Payments and FuturHealth, driving growth through flexible financing in retail and healthcare.
NEW YORK CITY, NY / ACCESS Newswire / March 26, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Affirm Holdings, Inc. ("Affirm" or "the Company") (NASDAQ:AFRM). Investors who purchased Affirm securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/AFRM.
Affirm is expanding its pay-later offering via a new agreement with J.P. Morgan Payments.
NEW YORK , March 25, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Affirm Holdings, Inc. ("Affirm" or the "Company") (NASDAQ: AFRM). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext.